CIK 0000879407 · Large accelerated filer
ARROWHEAD PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- ARWR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460408024
- Phone
- 626-696-4702
- Business address
- 177 E COLORADO BLVD, SUITE 700, PASADENA, CA, 91105
- Former names
- ARROWHEAD RESEARCH CORP, INTERACTIVE GROUP INC, INTERACTIVE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,186,600
- in 2 filings
Net −$1,186,600. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-01-01 | Anzalone Christopher Richard Chief Executive Officer | Grant or award | +800,000 | 4,045,828 | ||
| 2021-12-31 | O'Brien Patrick General Counsel | Option exercise | +28,000 | $6.15 | $172K | 321,375 |
| 2021-12-31 | O'Brien Patrick General Counsel | Option exercise · Stock Option (right to buy Common Stock) | −28,000 | 32,000 | ||
| 2021-12-28 | GIVEN DOUGLAS B Director | Gift | −655 | 109,213 | ||
| 2021-12-28 | GIVEN DOUGLAS B Director | Purchase | +655 | $66.37 | $43K | 109,868 |
| 2021-12-28 | Ferrari Mauro Director | Sale | −3,400 | $66.82 | $227K | 36,571 |
| 2021-12-23 | Anzalone Christopher Richard Chief Executive Officer | Option exercise | +11,806 | $5.19 | $61K | 3,245,828 |
| 2021-12-23 | Anzalone Christopher Richard Chief Executive Officer | Option exercise · Stock Option (right to buy Common Stock) | −11,806 | 773,227 | ||
| 2021-12-15 | Anzalone Christopher Richard Chief Executive Officer | Sale | −25,857 | $66.28 | $1.7M | 3,253,165 |
| 2021-12-15 | Anzalone Christopher Richard Chief Executive Officer | Sale | −14,857 | $67.19 | $998K | 3,238,308 |
| 2021-12-15 | Anzalone Christopher Richard Chief Executive Officer | Sale | −3,074 | $68.20 | $210K | 3,235,234 |
| 2021-12-15 | Anzalone Christopher Richard Chief Executive Officer | Sale | −9,223 | $69.52 | $641K | 3,226,011 |
| 2021-12-15 | Anzalone Christopher Richard Chief Executive Officer | Sale | −6,989 | $70.19 | $491K | 3,219,022 |
| 2021-11-19 | San Martin Javier Chief Medical Officer | Sale | −13,704 | $69.01 | $946K | 116,796 |
| 2021-11-19 | San Martin Javier Chief Medical Officer | Sale | −5,696 | $70.01 | $399K | 111,100 |
| 2021-11-19 | San Martin Javier Chief Medical Officer | Sale | −100 | $70.99 | $7K | 111,000 |
| 2021-10-22 | Anzalone Christopher Richard Chief Executive Officer | Sale | −44,170 | $65.57 | $2.9M | 3,284,852 |
| 2021-10-22 | Anzalone Christopher Richard Chief Executive Officer | Sale | −5,830 | $66.09 | $385K | 3,279,022 |
| 2021-10-20 | Anzalone Christopher Richard Chief Executive Officer | Sale | −15,000 | $66.23 | $993K | 3,329,022 |
| 2021-09-13 | OLUKOTUN ADEOYE Y Director | Sale | −2,250 | $63.76 | $143K | 11,750 |
Page 17 of 38 · 752 trades